Elizabeth Morgenthien

648 total citations
24 papers, 462 citations indexed

About

Elizabeth Morgenthien is a scholar working on Pulmonary and Respiratory Medicine, Ophthalmology and Epidemiology. According to data from OpenAlex, Elizabeth Morgenthien has authored 24 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Ophthalmology and 5 papers in Epidemiology. Recurrent topics in Elizabeth Morgenthien's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Respiratory and Cough-Related Research (5 papers) and Retinal Diseases and Treatments (5 papers). Elizabeth Morgenthien is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Respiratory and Cough-Related Research (5 papers) and Retinal Diseases and Treatments (5 papers). Elizabeth Morgenthien collaborates with scholars based in United States, Germany and Switzerland. Elizabeth Morgenthien's co-authors include Srinivas R. Sadda, Kenneth M. Marion, Siva Balasubramanian, Nizar Saleh Abdelfattah, Jianqin Lei, Wen Chyi Shyu, Rashmi H. Barbhaiya, Steven D. Nathan, John L. Stauffer and Susan L. Limb and has published in prestigious journals such as CHEST Journal, Ophthalmology and Pharmaceutical Research.

In The Last Decade

Elizabeth Morgenthien

24 papers receiving 450 citations

Peers

Elizabeth Morgenthien
Tsung‐Tien Wu Taiwan
John McKay Sweden
Fenq-Lih Lee Taiwan
Yanjiao Lu China
Mohammad Hossein Dehghan Iran
Yao Yang China
Suman Kalyan Paine India
Devendra Kumar Jain India
V. J. Marmion United Kingdom
Tsung‐Tien Wu Taiwan
Elizabeth Morgenthien
Citations per year, relative to Elizabeth Morgenthien Elizabeth Morgenthien (= 1×) peers Tsung‐Tien Wu

Countries citing papers authored by Elizabeth Morgenthien

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Morgenthien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Morgenthien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Morgenthien more than expected).

Fields of papers citing papers by Elizabeth Morgenthien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Morgenthien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Morgenthien. The network helps show where Elizabeth Morgenthien may publish in the future.

Co-authorship network of co-authors of Elizabeth Morgenthien

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Morgenthien. A scholar is included among the top collaborators of Elizabeth Morgenthien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Morgenthien. Elizabeth Morgenthien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jouneau, S., Bruno Crestani, Ronan Thibault, et al.. (2021). Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss. Respiration. 101(2). 142–154. 16 indexed citations
2.
Adrean, Sean D., et al.. (2020). Subretinal Fibrosis in HARBOR Varies by Choroidal Neovascularization Subtype. Ophthalmology Retina. 4(7). 752–754. 9 indexed citations
3.
Sadda, Srinivas R., Nizar Saleh Abdelfattah, Jianqin Lei, et al.. (2020). Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration. Ophthalmology. 127(10). 1360–1370. 45 indexed citations
4.
Gune, Shamika, Nizar Saleh Abdelfattah, Siva Balasubramanian, et al.. (2019). Spectral-Domain OCT–Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. Ophthalmology. 127(4). 523–532. 36 indexed citations
5.
Glassberg, Marilyn K., Steven D. Nathan, Chin‐Yu Lin, et al.. (2019). Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Advances in Therapy. 36(10). 2910–2926. 14 indexed citations
6.
Nassisi, Marco, Jianqin Lei, Nizar Saleh Abdelfattah, et al.. (2019). OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study. Ophthalmology. 126(12). 1667–1674. 112 indexed citations
7.
Nathan, Steven D., Ulrich Costabel, Carlo Albera, et al.. (2019). Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment. Respiratory Medicine. 153. 44–51. 55 indexed citations
8.
Sadda, Srinivas R., Elizabeth Morgenthien, & Shamika Gune. (2018). A longitudinal SD-OCT analysis of macular atrophy in the HARBOR trial. Investigative Ophthalmology & Visual Science. 59(9). 4481–4481. 2 indexed citations
9.
Haselkorn, Tmirah, Susan L. Limb, John L. Stauffer, et al.. (2018). Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Therapy. 4(1). 103–114. 3 indexed citations
10.
Nathan, Steven D., Ulrich Costabel, Carlo Albera, et al.. (2018). EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT. CHEST Journal. 154(4). 432A–433A. 1 indexed citations
11.
Nathan, Steven D., Ulrich Costabel, Ian Glaspole, et al.. (2018). Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis. CHEST Journal. 155(4). 712–719. 23 indexed citations
12.
Bhorade, Sangeeta, Elizabeth Morgenthien, Jessica R. Castle, Susan L. Limb, & Jayesh Mehta. (2018). Changes in neutrophil-lymphocyte and platelet-lymphocyte ratios and clinical outcomes in idiopathic pulmonary fibrosis. PA4805–PA4805. 2 indexed citations
13.
Willavize, Susan & Elizabeth Morgenthien. (2007). Nonparametric confidence intervals for Tmax in sequence‐stratified crossover studies. Pharmaceutical Statistics. 7(1). 9–19. 3 indexed citations
14.
Willavize, Susan & Elizabeth Morgenthien. (2006). Comparison of models for average bioequivalence in replicated crossover designs. Pharmaceutical Statistics. 5(3). 201–211. 7 indexed citations
15.
Chen, Hong, Philip Yu An Ding, Mau‐Song Chang, et al.. (1998). Pharmacokinetics of Fosinopril in Chinese Patients with Mild to Moderate Congestive Heart Failure. Clinical Drug Investigation. 16(5). 377–385. 1 indexed citations
16.
Vachharajani, Nimish N., Wen Chyi Shyu, William R. Garnett, Elizabeth Morgenthien, & Rashmi H. Barbhaiya. (1996). The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment. Clinical Pharmacology & Therapeutics. 60(3). 283–294. 11 indexed citations
17.
Shyu, Wen Chyi, Elizabeth Morgenthien, & Rashmi H. Barbhaiya. (1996). Pharmacokinetics of butorphanol nasal spray in patients with renal impairment. British Journal of Clinical Pharmacology. 41(5). 397–402. 8 indexed citations
18.
Schacter, Lee, et al.. (1994). Clinical and pharmacokinetic overview of parenteral etoposide phosphate. Cancer Chemotherapy and Pharmacology. 34(S1). S58–S63. 19 indexed citations
19.
Shyu, Wen Chyi, Kelly Pittman, Rashmi H. Barbhaiya, & Elizabeth Morgenthien. (1994). The effects of age and sex on the systemic. European Journal of Clinical Pharmacology. 47(1). 57–60. 16 indexed citations
20.
Knupp, Catherine A., Wen Chyi Shyu, Elizabeth Morgenthien, James Lee, & Rashmi H. Barbhaiya. (1993). Biopharmaceutics of Didanosine in Humans and in a Model for Acid-Labile Drugs, the Pentagastrin-Pretreated Dog. Pharmaceutical Research. 10(8). 1157–1164. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsung‐Tien Wu Breakdown of academic impact, for papers by John McKay Breakdown of academic impact, for papers by Fenq-Lih Lee Breakdown of academic impact, for papers by Yanjiao Lu Breakdown of academic impact, for papers by Mohammad Hossein Dehghan Breakdown of academic impact, for papers by Yao Yang Breakdown of academic impact, for papers by Suman Kalyan Paine Breakdown of academic impact, for papers by Devendra Kumar Jain Breakdown of academic impact, for papers by V. J. Marmion
Rankless by CCL
2026